Literature DB >> 26427702

Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition.

Jennifer Struble1, Shannon Reid2, Mohamed A Bedaiwy3.   

Abstract

Adenomyosis is a heterogenous gynecologic condition. Patients with adenomyosis can have a range of clinical presentations. The most common presentation of adenomyosis is heavy menstrual bleeding and dysmenorrhea; however, patients can also be asymptomatic. Currently, there are no standard diagnostic imaging criteria, and choosing the optimal treatment for patients is challenging. Women with adenomyosis often have other associated gynecologic conditions such as endometriosis or leiomyomas, therefore making the diagnosis and evaluating response to treatment challenging. The objective of this review was to highlight current clinical information regarding the epidemiology, risk factors, pathogenesis, clinical manifestations, diagnosis, imaging findings, and treatment of adenomyosis. Several studies support the theory that adenomyosis results from invasion of the endometrium into the myometrium, causing alterations in the junctional zone. These changes are commonly seen on imaging studies such as transvaginal ultrasound (TVUS) and magnetic resonance imaging (MRI). The second most common theory is that adenomyosis results from embryologic-misplaced pluripotent mullerian remnants. Traditionally, adenomyosis was only diagnosed after hysterectomy; however, studies have shown that a diagnosis can be made with biopsies at hysteroscopy and laparoscopy. Noninvasive imaging can be used to help guide the differential diagnosis. The most common findings on 2-dimensional/3-dimensional TVUS and MRI are reviewed. Two-dimensional TVUS and MRI have a respectable sensitivity and specificity; however, recent studies indicate that 3-dimensional TVUS is superior to 2-dimensional TVUS for the diagnosis of adenomyosis and may allow for the diagnosis of early-stage disease. Management options for adenomyosis, both medical and surgical, are reviewed. Currently, the only definitive management option for patients is hysterectomy.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Adenomyosis; Imaging diagnostic criteria

Mesh:

Year:  2015        PMID: 26427702     DOI: 10.1016/j.jmig.2015.09.018

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  49 in total

1.  Accuracy of findings in the diagnosis of uterine adenomyosis on ultrasound.

Authors:  Medica Sam; Monique Raubenheimer; Florin Manolea; Hector Aguilar; Rishi P Mathew; Vimal H Patel; Gavin Low
Journal:  Abdom Radiol (NY)       Date:  2020-03

2.  TGF-β1 Neutralization Improves Pregnancy Outcomes by Restoring Endometrial Receptivity in Mice with Adenomyosis.

Authors:  Nari Kay; Chun-Yen Huang; Li-Yen Shiu; Ya-Chun Yu; Yu Chang; Frederick Schatz; Jau-Ling Suen; Eing-Mei Tsai; S Joseph Huang
Journal:  Reprod Sci       Date:  2020-09-09       Impact factor: 3.060

3.  MicroRNA-17 downregulates expression of the PTEN gene to promote the occurrence and development of adenomyosis.

Authors:  Haiyan Hu; Huijuan Li; Yuanli He
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

4.  Environmental risk factors for endometriosis: A critical evaluation of studies and recommendations from the epidemiologic perspective.

Authors:  Kristen Upson
Journal:  Curr Epidemiol Rep       Date:  2020-08-18

Review 5.  Adenomyosis and infertility.

Authors:  Gaby Moawad; Mira H Kheil; Jean Marc Ayoubi; Jordan S Klebanoff; Sara Rahman; Fady I Sharara
Journal:  J Assist Reprod Genet       Date:  2022-03-28       Impact factor: 3.412

6.  Pathology and Pathogenesis of Adenomyosis.

Authors:  Maria Facadio Antero; Ayse Ayhan; James Segars; Ie-Ming Shih
Journal:  Semin Reprod Med       Date:  2020-10-20       Impact factor: 1.303

7.  The effect of adenomyosis on the outcomes of laparoscopic hysterectomy.

Authors:  Ali Yavuzcan; Alper Başbuğ; Merve Baştan; Mete Çağlar; İsmail Özdemir
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-09-01

Review 8.  Exposure to the environmental endocrine disruptor TCDD and human reproductive dysfunction: Translating lessons from murine models.

Authors:  Kaylon L Bruner-Tran; Juan Gnecco; Tianbing Ding; Dana R Glore; Virginia Pensabene; Kevin G Osteen
Journal:  Reprod Toxicol       Date:  2016-07-14       Impact factor: 3.143

9.  [The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis].

Authors:  Junyao Lou; Xiufeng Huang; Lifeng Zhang; Ping Xu; Xinmei Zhang; Zhengyun Chen
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-25

10.  Sonographic Signs of Adenomyosis in Women with Endometriosis Are Associated with Infertility.

Authors:  Dean Decter; Nissim Arbib; Hila Markovitz; Daniel S Seidman; Vered H Eisenberg
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.